PMID: 12757269May 22, 2003Paper

Dilemmas in regulation of the market for pharmaceuticals

Health Affairs
Alan Maynard, Karen Bloor

Abstract

What can be learned from international experience of efforts to control spending and to improve efficiency and access in pharmaceutical markets? Policymakers tend to reinvent many policies to control the behavior of patients, doctors, and industry, despite a lack of evidence of those policies' cost-effectiveness. There is an emerging consensus that reimbursement in public and private health care systems should be informed by evidence of the cost-effectiveness of treatments and that utilization should be constrained by budget caps and information systems. Whatever the policy chosen, evaluation is as essential as it is rare.

References

Apr 15, 1995·BMJ : British Medical Journal·N FreemantleG Torrance
Sep 1, 1994·Health Economics·J M vd Schulenburg
Jul 26, 1997·BMJ : British Medical Journal·A Maynard, K Bloor
Oct 7, 1997·BMJ : British Medical Journal·A Giuffrida, D J Torgerson
Sep 29, 2001·BMJ : British Medical Journal·R CooksonA Maynard
Dec 26, 2001·JAMA : the Journal of the American Medical Association·J MasonM Drummond
Feb 15, 2002·The New England Journal of Medicine·Alan F Holmer
Aug 3, 2002·BMJ : British Medical Journal·Silvio Garattini, Vittorio Bertele

❮ Previous
Next ❯

Citations

Dec 23, 2006·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Patricia L Willert
Jun 26, 2007·Pharmacy World & Science : PWS·Jana DavidovaCecilia Stålsby Lundborg
Feb 6, 2004·The New England Journal of Medicine·Michelle M MelloTroyen A Brennan
Mar 16, 2004·Annual Review of Public Health·Judith L Wagner, Elizabeth McCarthy
Apr 21, 2010·American Journal of Public Health·Salomeh KeyhaniGerard Anderson
Jan 26, 2007·Applied Health Economics and Health Policy·Tom Stargardt, Jonas Schreyögg
Sep 15, 2006·Journal of the American Geriatrics Society·Muriel R Gillick
Nov 19, 2011·Health Services Research·Vincenzo AtellaLorenzo Carbonari
Oct 6, 2009·Pharmacoepidemiology and Drug Safety·Katy J L BellJonathan C Craig
May 10, 2005·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·June M TordoffDavid M Reith
Sep 12, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Katri AaltonenPauline Norris
Dec 22, 2009·Human Resources for Health·Carl-Ardy Dubois, Debbie Singh
Jun 29, 2010·Human Resources for Health·Amanda K TyrrellPaulo Ferrinho
Aug 5, 2015·The Cochrane Database of Systematic Reviews·Arash RashidianAndrew D Oxman
Aug 19, 2009·Annals of the New York Academy of Sciences·Francesco Bonadonna
Sep 12, 2009·Evolution; International Journal of Organic Evolution·Michael J Sheehan, Elizabeth A Tibbetts
Nov 26, 2009·Evolution; International Journal of Organic Evolution·Alexis S ChaineJean Clobert
Feb 13, 2010·Evolution; International Journal of Organic Evolution·Muna AgbaliCarl Smith
Feb 13, 2010·Journal of Evolutionary Biology·P Carazo, E Font
Feb 1, 2010·Oikos·Matina C Donaldson-MatasciMichael Lachmann
May 14, 2011·Cognitive Science·Thomas C Scott-Phillips
Sep 21, 2010·American Journal of Physical Anthropology·Seth D Dobson
Jun 30, 2010·Evolution; International Journal of Organic Evolution·Carl Smith, Duncan Greig
Jun 22, 2010·Evolution; International Journal of Organic Evolution·Carlos A BoteroFranz J Weissing
Jul 16, 2010·Evolution; International Journal of Organic Evolution·Jukka KekäläinenRaine Kortet
Sep 15, 2005·Health Economics·Adam Oliver
May 22, 2003·Health Affairs·Panos Kanavos, Uwe Reinhardt
Jun 18, 2015·Revista de saúde pública·Nathália Molleis Miziara, Diogo Rosenthal Coutinho
May 5, 2021·International Journal of Technology Assessment in Health Care·Pedro Serrano-AguilarCristina González Del Yerro-Valdés

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Clinical Pharmacology and Therapeutics
Hans-Georg Eichler
Journal of Affective Disorders
Scott PattenSerge Beaulieu
© 2022 Meta ULC. All rights reserved